Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8434-8439

  Marusic, C ^a   Rizza, P ^a   Lattanzi, L ^a   Mancini, C ^a   Spada, M ^a   Belardelli, F ^a   Benvenuto, E ^a   Capone, I ^a  

^a ENEA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; COAT PROTEIN; EPITOPE; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PLANT VIRUS; PRIORITY JOURNAL; SCID MOUSE; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; CAPSID; CAPSID PROTEINS; EPITOPES, B-LYMPHOCYTE; FEMALE; GENETIC ENGINEERING; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, INBRED C57BL; MICE, SCID; MOLECULAR SEQUENCE DATA; POTEXVIRUS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VIRION;

EID: 0034881226     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8434-8439.2001     Document Type: Article

References (38)

1. Potexvirus isolation and RNA extraction
2. High-tech herbal medicine: Plant-based vaccines
3. The organization of potato virus X coat proteins in virus particles studied by tritium planigraphy and model building
4. The topography of the surface of potato virus X: Tritium planigraphy and immunological analysis
5. Jellyfish green fluorescent protein as a reporter for virus infections
6. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice
7. A chimaeric plant virus vaccine protects mice against a bacterial infection
8. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
9. A vaccine for HIV type 1: The antibody perspective
10. Mucosal immunity and tolerance: Relevance to vaccine development
11. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type I on recombinant surface antigen of hepatitis B virus
12. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
13. Transgenic plants as factories for biopharmaceuticals
14. Presentation of heterologous peptides on plant viruses: Genetics, structure and function
15. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope
16. SCID mouse models: More than furry flasks
17. A rationale basis for mucosal vaccination against HIV infection
18. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines
19. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene
20. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus
21. Immunization against rabies with plant-derived antigen
22. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS
23. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
24. Simple, rapid, quantitative syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
25. Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles
26. Type 1 IFNs and regulation of TH1 responses: Enigmas both resolved and emerge
27. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
28. Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5
29. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
30. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein
31. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat
32. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
33. Cytokine profiles in HIV type 1 disease and protection
34. Production of a functional single chain antibody attached to the surface of a plant virus
35. The human immune system in hu-PBL-SCID mice
36. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus
37. Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody
38. Plants as vectors for biomedical products